DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neutropenia (123)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 123   Next >>

Possible Prednisolone side effects in male

Reported by a physician from Germany on 2012-08-24

Patient: male

Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-17

Doxorubicin Hydrochloride
    Dosage: 100 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-17

Neulasta
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-06
    End date: 2012-04-20

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-21

Rituximab
    Dosage: 750 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-01
    End date: 2012-04-16

Vincristine
    Dosage: 2 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-17

Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir



Possible Prednisolone side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Adriamycin PFS
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etoposide
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium



Possible Prednisolone side effects in male

Reported by a physician from United Kingdom on 2012-08-21

Patient: male

Reactions: Pelvic Pain, Pyrexia, Anal Fistula, C-Reactive Protein Increased, Splenomegaly, Rectal Abscess, Lethargy, Hepatosplenic T-Cell Lymphoma, Crohn's Disease, Sepsis, Platelet Count Decreased, Diabetic Ketoacidosis, Neutropenia, Rectal Discharge, Leukopenia, Influenza Like Illness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Azathioprine Sodium
    Dosage: 2.5 mg/kg
    Indication: Crohn's Disease

Azathioprine Sodium
    Start date: 2002-01-01
    End date: 2006-09-01

Azathioprine Sodium
    Start date: 2001-06-01

Mercaptopurine
    Indication: Crohn's Disease

Prednisolone
    Indication: Product Used FOR Unknown Indication

Remicade
    Indication: Crohn's Disease
    End date: 2005-09-29

Remicade
    Dosage: stopped in february - march (3rd infusion)
    End date: 2006-02-01

Other drugs received by patient: Metronidazole; Vitamin B-12



Possible Prednisolone side effects in

Reported by a physician from Korea, Republic of on 2012-08-02

Patient:

Reactions: Pneumonia, Neutropenia, Thrombocytopenia, Septic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 18 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Melphalan Hydrochloride
    Dosage: 11 mg/m2, unk
    Start date: 2012-03-22
    End date: 2012-03-25

Prednisolone
    Dosage: 58 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-04-01



Possible Prednisolone side effects in 77 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Blood Urea Increased, Pneumonia, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: 625 mg, qd
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-05-18

Exjade
    Dosage: 625 mg, on alternate days
    Administration route: Oral
    Start date: 2011-05-19

Exjade
    Dosage: 750 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-16
    End date: 2011-04-03

Prednisolone
    Dosage: 5 mg daily
    Administration route: Oral
    Start date: 2010-04-22

Prednisolone
    Dosage: 8 mg, daily
    Administration route: Oral
    End date: 2009-09-29

Prednisolone
    Dosage: 7 mg, daily
    Administration route: Oral
    Start date: 2009-09-30
    End date: 2010-02-02

Prednisolone
    Dosage: 6 mg, daily
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2010-04-21

Prednisolone
    Dosage: 4 mg, unk
    Administration route: Oral

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-04-12
    End date: 2011-05-02

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Other drugs received by patient: Equa; Xalatan; Desferal; Famotidine; Novolin R; RED Blood Cells, Concentrated; Glufast; Novolin R; RED Blood Cells, Concentrated; Alendronate Sodium; Timoptol-XE; Platelets; Novolin R; Amaryl; Novolin R; Azopt; Platelets; Famotidine; Glufast; Clarithromycin; Desferal; Desferal; Mucodyne; Voglibose



Possible Prednisolone side effects in 77 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Pneumonia, Blood Urea Increased, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: 750 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-16
    End date: 2011-04-03

Exjade
    Dosage: 625 mg, on alternate days
    Administration route: Oral
    Start date: 2011-05-19

Exjade
    Dosage: 625 mg, qd
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-05-18

Prednisolone
    Dosage: 8 mg, daily
    Administration route: Oral
    End date: 2009-09-29

Prednisolone
    Dosage: 7 mg, daily
    Administration route: Oral
    Start date: 2009-09-30
    End date: 2010-02-02

Prednisolone
    Dosage: 6 mg, daily
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2010-04-21

Prednisolone
    Dosage: 4 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 5 mg daily
    Administration route: Oral
    Start date: 2010-04-22

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-04-12
    End date: 2011-05-02

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Other drugs received by patient: Platelets; Novolin R; Clarithromycin; Xalatan; Desferal; Novolin R; RED Blood Cells, Concentrated; Mucodyne; Famotidine; Famotidine; Azopt; Platelets; Desferal; RED Blood Cells, Concentrated; Alendronate Sodium; Voglibose; Timoptol-XE; Amaryl; Novolin R; Novolin R; Glufast; Glufast; Desferal; Equa



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Prednisolone side effects in

Reported by a physician from Japan on 2012-07-17

Patient:

Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Neupogen
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Rituxan
    Dosage: 6 doses-2 days prior to each cycle of chop
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Prednisolone side effects in male

Reported by a physician from Germany on 2012-07-16

Patient: male

Reactions: Neutropenia, Lymphocytic Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Mabthera
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-16

Neulasta
    Indication: B-Cell Lymphoma
    Start date: 2012-04-20
    End date: 2012-04-20

Prednisolone
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-21

Vincristine
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Other drugs received by patient: Metoclopramide; Morphine Sulphate Drip; Acyclovir; Dipyrone TAB; Pantoprazole



Possible Prednisolone side effects in 32 year old male

Reported by a individual with unspecified qualification from Hungary on 2012-07-10

Patient: 32 year old male

Reactions: Hepatic Function Abnormal, Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-01
    End date: 2011-11-01

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-01
    End date: 2011-11-01

Prednisolone
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-01
    End date: 2011-11-01

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-01
    End date: 2011-11-01

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-08-01
    End date: 2011-11-01



Possible Prednisolone side effects in male

Reported by a physician from Germany on 2012-07-10

Patient: male

Reactions: Neutropenia, Lymphocytic Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Neulasta
    Dosage: 6 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-20
    End date: 2012-04-20

Prednisolone
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-21

Rituxan
    Dosage: 750 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-16

Vincristine
    Dosage: 2 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Other drugs received by patient: Morphine Sulfate; Acyclovir; Metoclopramide; Dipyrone TAB; Pantoprazole



Possible Prednisolone side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-05

Patient:

Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Neupogen
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Rituximab
    Dosage: 6 doses-2 days prior to each cycle of chop
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Prednisolone side effects in female

Reported by a physician from Germany on 2012-06-28

Patient: female

Reactions: White Blood Cell Count Decreased, C-Reactive Protein Increased, Sepsis, Hypotension, Presyncope, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Mabthera
    Indication: B-Cell Lymphoma
    Start date: 2012-04-25

Neulasta
    Dosage: daily dose 6 mg, 2 x(29 apr 2012+17 may 2012
    Indication: B-Cell Lymphoma
    Start date: 2012-04-29

Prednisolone
    Dosage: frequency 1 times in 2 week for 5 days
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26
    End date: 2012-04-30

Vincristine
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Other drugs received by patient: Enoxaparin Natrium; Aspirin; Ramipril; Tiotropium Bromide; Nebivolol; Torsemide; Pantoprazole; Levothyroxine Sodium; Acyclovir; Simvastatin; Trimethoprim + Sulfamethoxazole



Possible Prednisolone side effects in

Reported by a physician from France on 2012-06-27

Patient:

Reactions: Febrile Neutropenia, Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1, every 21 days for 6 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1, every 21 days for 6 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Dosage: on days 1-5, every 21 days for 6 cycles
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: on day 1, every 21 days for 6 cycles
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: on day 1, every 21 days for 6 cycles
    Indication: Diffuse Large B-Cell Lymphoma



Possible Prednisolone side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26

Patient: female

Reactions: Syncope, Sepsis, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1493 m
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Doxorubicin HCL
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Neulasta
    Indication: B-Cell Lymphoma
    Start date: 2012-04-29

Prednisolone
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26
    End date: 2012-04-30

Rituximab
    Indication: B-Cell Lymphoma
    Start date: 2012-04-25

Vincristine
    Dosage: 3.94 m
    Indication: B-Cell Lymphoma
    Start date: 2012-04-26

Other drugs received by patient: Simvastatin; Levothyroxine; Ramipril; Acyclovir; Acetylsalicylic Acid SRT; Enoxaparin Sodium; Tiotropium Bromide; Trimethoprim + Sulfamethoxazole; Torsemide; Pantoprazole; Nebivolol



Possible Prednisolone side effects in 66 year old female

Reported by a physician from Finland on 2012-06-26

Patient: 66 year old female

Reactions: Swelling Face, Nausea, Hepatic Enzyme Increased, Acute Tonsillitis, Sepsis, Neutropenia, Rash Morbilliform, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 10 mg, unk
    Indication: Seronegative Arthritis
    Start date: 2012-01-01

Sulfasalazine
    Dosage: unk
    Indication: Seronegative Arthritis
    Start date: 2012-01-01
    End date: 2012-05-01

Other drugs received by patient: Calcium Carbonate; Pantoprazole



Possible Prednisolone side effects in

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-26

Patient:

Reactions: Abdominal Pain, Hyperbilirubinaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Rash, Pyrexia, Peripheral Sensory Neuropathy, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Asthenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: given on day 1 of each cycle
    Indication: B-Cell Lymphoma

Mabthera
    Dosage: on day 1 of every cycle
    Indication: B-Cell Lymphoma

Prednisolone
    Dosage: given on days 1 to 5 of every cycle (repeated every 3 weeks)
    Administration route: Oral
    Indication: B-Cell Lymphoma

Vincristine
    Dosage: given on day 1 of every cycle; dose: 1.4 mg/m2 ( maximum 2.0 mg)
    Indication: B-Cell Lymphoma



Possible Prednisolone side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 30 year old female

Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Peritonitis, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 54 year old male

Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Infection

Drug(s) suspected as cause:
Bleomycin
    Dosage: 10 mg/m2, day 8
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Etoposide
    Dosage: 200 mg/m2, day1-3
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-14
    Indication: Chemotherapy

Procarbacin
    Dosage: 100 mg/m2, day 1-7

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 37 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 37 year old male

Reactions: Neutropenia

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 90 mg/m2, day1-2
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 49 year old male

Reactions: Neutropenia, Infection

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 90 mg/m2, day1-2
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21

Patient: 67 year old male

Reactions: Neutropenia, Infection

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 90 mg/m2, day1-2
    Indication: Chemotherapy

Cyclophosphamide
    Dosage: 750 mg/m2, day1
    Indication: Chemotherapy

Doxorubicin HCL
    Dosage: 50 mg/m2, day1
    Indication: Chemotherapy

Prednisolone
    Dosage: 100 mg, day1-5
    Indication: Chemotherapy

Vincristine
    Dosage: 1.4 mg/m2, day1
    Indication: Chemotherapy



Possible Prednisolone side effects in

Reported by a individual with unspecified qualification from Austria on 2012-06-18

Patient:

Reactions: Cardiac Failure, Febrile Neutropenia, Cardiotoxicity, Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Mabthera
    Indication: Diffuse Large B-Cell Lymphoma

Prednisolone
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine Sulfate
    Indication: Diffuse Large B-Cell Lymphoma



Possible Prednisolone side effects in 77 year old male

Reported by a physician from Japan on 2012-06-18

Patient: 77 year old male, weighing 67.0 kg (147.3 pounds)

Reactions: Gastrointestinal Haemorrhage, Pyrexia, Ammonia Decreased, Blood Bilirubin Decreased, Liver Disorder, C-Reactive Protein Increased, Depressed Level of Consciousness, Neutropenia, Blood Pressure Decreased, Melaena, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose: 70mg/m2/day
    Indication: Prostate Cancer Recurrent
    Start date: 2012-05-22
    End date: 2012-05-22

Prednisolone
    Indication: Prostate Cancer Recurrent
    Start date: 2012-05-22



Possible Prednisolone side effects in 59 year old male

Reported by a physician from Finland on 2012-06-15

Patient: 59 year old male, weighing 113.0 kg (248.6 pounds)

Reactions: Pneumonia, Haematuria, Neutropenia, Leukopenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Indication: Prostate Cancer
    Start date: 2011-03-16
    End date: 2011-03-16

Cabazitaxel
    Start date: 2012-04-03
    End date: 2012-04-03

Prednisolone
    Start date: 2010-04-22

Other drugs received by patient: Calcichew-D3; Selocomp ZOC; Felodipine; Androcur; Lasix; Ibuprofen; Nexium; Xatral CR; Zoladex



Possible Prednisolone side effects in 67 year old male

Reported by a physician from Germany on 2012-06-11

Patient: 67 year old male

Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bendamustine

Bendamustine
    Indication: Plasmablastic Lymphoma

Bendamustine
    Dosage: part of r-chop chemotherapy; later received with bendamustine

Cyclophosphamide
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Cyclosporine
    Dosage: 200 milligram;
    Indication: Immunosuppressant Drug Therapy

Doxorubicin HCL
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Prednisolone
    Dosage: 5 milligram;
    Indication: Immunosuppressant Drug Therapy

Prednisone TAB
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Rituximab
    Dosage: part of r-chop chemotherapy; later received with bendamustine

Rituximab

Rituximab
    Dosage: 2 cycles; followed by r-chop
    Indication: Plasmablastic Lymphoma

Vincristine
    Dosage: part of r-chop chemotherapy
    Indication: Plasmablastic Lymphoma

Other drugs received by patient: Immune Globulin NOS



Possible Prednisolone side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11

Patient: 43 year old male

Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Amphotericin B
    Indication: Aspergillosis

Ciprofloxacin HCL
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Ciprofloxacin HCL
    Dosage: 60 mg

Clarithromycin
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Cyclophosphamide
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Immunosuppression

Meropenem
    Dosage: 1 g, 2x/day
    Indication: Product Used FOR Unknown Indication

Oseltamivir
    Dosage: 75 mg, 2x/day
    Indication: Product Used FOR Unknown Indication

Prednisolone
    Dosage: 60 mg, unk
    Indication: Immunosuppression

Teicoplanin
    Dosage: 400 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Voriconazole
    Dosage: unk
    Indication: Aspergillosis



Possible Prednisolone side effects in male

Reported by a physician from Germany on 2012-06-11

Patient: male

Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-17

Doxorubicin HCL
    Dosage: 100 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-17

Neulasta
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-06
    End date: 2012-04-20

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-21

Rituximab
    Dosage: 750 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-01
    End date: 2012-04-16

Vincristine
    Dosage: 2 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-02-02
    End date: 2012-04-17

Other drugs received by patient: Rulid; Electrolytes NOS W / Macrogol 3350; Acyclovir; Dipyrone TAB; Metoclopramide; Pantoprazole; MST / 00036302 /; Novalgin / 00169801 /; Paspertin / 00041902 /; Acyclovir



Possible Prednisolone side effects in 37 year old male

Reported by a physician from Germany on 2012-06-11

Patient: 37 year old male

Reactions: Plasmablastic Lymphoma, Post Transplant Lymphoproliferative Disorder, Neutropenia

Drug(s) suspected as cause:
Azathioprine
    Dosage: 100 milligram;
    Indication: Immunosuppressant Drug Therapy

Cyclophosphamide
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Cyclosporine
    Dosage: 100 milligram;
    Indication: Immunosuppressant Drug Therapy

Doxorubicin HCL
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Prednisolone
    Dosage: 2.5 milligram;
    Indication: Immunosuppressant Drug Therapy

Prednisolone
    Dosage: 100mg, d1-5 of 22d cycle; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Vincristine
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Other drugs received by patient: Sirolimus



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Germany on 2012-06-08

Patient: 49 year old male

Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Cyclosporine
    Dosage: 325 milligram;
    Indication: Immunosuppressant Drug Therapy

Doxorubicin HCL
    Dosage: on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Prednisolone
    Dosage: 100mg, d1-5 of 22d cycle; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma

Vincristine
    Dosage: (max 2mg) on d1; chop-21 chemotherapy
    Indication: Plasmablastic Lymphoma



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017